Ovarian cancer forces into new tissues

Ovarian tumor cells use cellular movement proteins to penetrate protective cell layers surrounding new target tissues during metastasis.

Written byJessica P. Johnson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Ovarian cancer cells (left) push their way through a layer of mesothelial cells, leaving a hole (right)MARCIN IWANICKI AND RACHEL DAVIDOWITZ HARVARD MEDICAL SCHOOL

When an ovarian tumor begins to spread, its first targets are the other organs within the abdominal cavity, which are protected by a layer of epithelial cells known as the mesothelium. Now, scientists have discovered how ovarian cancer cells breach that barrier to create new tumors -- brute force. According to a study published online today (June 14) in Cancer Discovery, ovarian cancers use proteins involved in cellular movement to muscle their way past the cellular barrier.

“You can use the analogy of a snowplow,” said Ernst Lengyel, associate professor of gynecologic oncology at the University of Chicago, who was not involved in the research. In essence, he said, the tumor cells shovel healthy mesothelial cells out of their way to get to underlying organs.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies